

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 5.54631448 |
| 2 | sulfur amino acid catabolic process (GO:0000098) | 5.22614584 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.15590586 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.15590586 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.13676069 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.13676069 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.87476881 |
| 8 | negative regulation of fibrinolysis (GO:0051918) | 4.60505207 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 4.58677366 |
| 10 | desmosome organization (GO:0002934) | 4.54808532 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 4.48112689 |
| 12 | glyoxylate metabolic process (GO:0046487) | 4.47724686 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.44985039 |
| 14 | protein carboxylation (GO:0018214) | 4.44985039 |
| 15 | kynurenine metabolic process (GO:0070189) | 4.22671542 |
| 16 | cysteine metabolic process (GO:0006534) | 4.21914245 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.13761860 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.13761860 |
| 19 | tryptophan catabolic process (GO:0006569) | 4.13761860 |
| 20 | complement activation, alternative pathway (GO:0006957) | 4.13472099 |
| 21 | regulation of fibrinolysis (GO:0051917) | 4.13388273 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 4.13006063 |
| 23 | urea cycle (GO:0000050) | 4.10606847 |
| 24 | urea metabolic process (GO:0019627) | 4.10606847 |
| 25 | bile acid biosynthetic process (GO:0006699) | 4.09912297 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.09331136 |
| 27 | regulation of protein activation cascade (GO:2000257) | 4.03318906 |
| 28 | homocysteine metabolic process (GO:0050667) | 3.97880835 |
| 29 | cellular modified amino acid catabolic process (GO:0042219) | 3.97668287 |
| 30 | tryptophan metabolic process (GO:0006568) | 3.91210148 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 3.90213852 |
| 32 | lysine metabolic process (GO:0006553) | 3.87361970 |
| 33 | lysine catabolic process (GO:0006554) | 3.87361970 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 3.86363299 |
| 35 | plasma lipoprotein particle clearance (GO:0034381) | 3.84202712 |
| 36 | regulation of complement activation (GO:0030449) | 3.83206569 |
| 37 | epoxygenase P450 pathway (GO:0019373) | 3.82671211 |
| 38 | cellular glucuronidation (GO:0052695) | 3.77719724 |
| 39 | reverse cholesterol transport (GO:0043691) | 3.76519048 |
| 40 | nitrogen cycle metabolic process (GO:0071941) | 3.75107929 |
| 41 | coenzyme catabolic process (GO:0009109) | 3.74219024 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 3.65654083 |
| 43 | macromolecular complex remodeling (GO:0034367) | 3.65654083 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 3.65654083 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 3.65557358 |
| 46 | negative regulation of cholesterol transport (GO:0032375) | 3.63519197 |
| 47 | negative regulation of sterol transport (GO:0032372) | 3.63519197 |
| 48 | serine family amino acid catabolic process (GO:0009071) | 3.63084690 |
| 49 | phospholipid efflux (GO:0033700) | 3.62226383 |
| 50 | flavonoid metabolic process (GO:0009812) | 3.58676858 |
| 51 | bile acid and bile salt transport (GO:0015721) | 3.56664915 |
| 52 | bile acid metabolic process (GO:0008206) | 3.54727752 |
| 53 | primary alcohol catabolic process (GO:0034310) | 3.52505184 |
| 54 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.52360297 |
| 55 | adhesion of symbiont to host (GO:0044406) | 3.51988125 |
| 56 | regulation of cholesterol homeostasis (GO:2000188) | 3.50316937 |
| 57 | triglyceride homeostasis (GO:0070328) | 3.48959339 |
| 58 | acylglycerol homeostasis (GO:0055090) | 3.48959339 |
| 59 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.47090742 |
| 60 | adhesion of symbiont to host cell (GO:0044650) | 3.46821959 |
| 61 | virion attachment to host cell (GO:0019062) | 3.46821959 |
| 62 | lipoprotein metabolic process (GO:0042157) | 3.44175172 |
| 63 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.38388630 |
| 64 | glucuronate metabolic process (GO:0019585) | 3.38267282 |
| 65 | uronic acid metabolic process (GO:0006063) | 3.38267282 |
| 66 | endothelial cell chemotaxis (GO:0035767) | 3.35533573 |
| 67 | ethanol oxidation (GO:0006069) | 3.33801433 |
| 68 | fibrinolysis (GO:0042730) | 3.32742222 |
| 69 | drug catabolic process (GO:0042737) | 3.32500437 |
| 70 | aromatic amino acid family metabolic process (GO:0009072) | 3.31622667 |
| 71 | positive regulation of lipid catabolic process (GO:0050996) | 3.26207820 |
| 72 | carnitine metabolic process (GO:0009437) | 3.22814162 |
| 73 | low-density lipoprotein particle clearance (GO:0034383) | 3.22418487 |
| 74 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.22073726 |
| 75 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.22073726 |
| 76 | alpha-amino acid catabolic process (GO:1901606) | 3.21810600 |
| 77 | tyrosine metabolic process (GO:0006570) | 3.21104868 |
| 78 | hormone catabolic process (GO:0042447) | 3.20570991 |
| 79 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.19642798 |
| 80 | drug metabolic process (GO:0017144) | 3.19105340 |
| 81 | response to nitrosative stress (GO:0051409) | 3.18766044 |
| 82 | skin morphogenesis (GO:0043589) | 3.17743495 |
| 83 | xenobiotic catabolic process (GO:0042178) | 3.17417302 |
| 84 | cellular amino acid catabolic process (GO:0009063) | 3.16593400 |
| 85 | valine metabolic process (GO:0006573) | 3.16536955 |
| 86 | basement membrane organization (GO:0071711) | 3.16122559 |
| 87 | fatty acid beta-oxidation (GO:0006635) | 3.16073686 |
| 88 | cholesterol homeostasis (GO:0042632) | 3.14562841 |
| 89 | cellular ketone body metabolic process (GO:0046950) | 3.14023871 |
| 90 | endosome to pigment granule transport (GO:0043485) | 3.13723520 |
| 91 | endosome to melanosome transport (GO:0035646) | 3.13723520 |
| 92 | regulation of plasminogen activation (GO:0010755) | 3.12220649 |
| 93 | sterol homeostasis (GO:0055092) | 3.11787689 |
| 94 | fatty acid oxidation (GO:0019395) | 3.10691008 |
| 95 | phospholipid homeostasis (GO:0055091) | 3.09654358 |
| 96 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.08366617 |
| 97 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.07243276 |
| 98 | cofactor catabolic process (GO:0051187) | 3.06257514 |
| 99 | benzene-containing compound metabolic process (GO:0042537) | 3.06217762 |
| 100 | cholesterol efflux (GO:0033344) | 3.04633368 |
| 101 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.04467512 |
| 102 | lipid oxidation (GO:0034440) | 3.04150206 |
| 103 | serine family amino acid metabolic process (GO:0009069) | 3.03399686 |
| 104 | negative regulation of fatty acid transport (GO:2000192) | 3.02431695 |
| 105 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.02399753 |
| 106 | glycine metabolic process (GO:0006544) | 3.01961318 |
| 107 | regulation of cholesterol metabolic process (GO:0090181) | 3.00951833 |
| 108 | plasma lipoprotein particle assembly (GO:0034377) | 2.99501533 |
| 109 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.98971451 |
| 110 | acute-phase response (GO:0006953) | 2.98160487 |
| 111 | aldehyde catabolic process (GO:0046185) | 2.97925329 |
| 112 | short-chain fatty acid metabolic process (GO:0046459) | 2.96088873 |
| 113 | mannose metabolic process (GO:0006013) | 2.94745015 |
| 114 | ethanol metabolic process (GO:0006067) | 2.91661050 |
| 115 | positive regulation of fatty acid oxidation (GO:0046321) | 2.91307839 |
| 116 | exogenous drug catabolic process (GO:0042738) | 2.90881983 |
| 117 | cell-substrate junction assembly (GO:0007044) | 2.89782770 |
| 118 | low-density lipoprotein particle remodeling (GO:0034374) | 2.89526035 |
| 119 | fatty acid catabolic process (GO:0009062) | 2.88517249 |
| 120 | iron ion import (GO:0097286) | 2.84456253 |
| 121 | type B pancreatic cell proliferation (GO:0044342) | 2.78216244 |
| 122 | macroautophagy (GO:0016236) | 2.77095685 |
| 123 | renal filtration (GO:0097205) | 2.76310224 |
| 124 | amyloid precursor protein catabolic process (GO:0042987) | 2.69038393 |
| 125 | positive regulation of histone deacetylation (GO:0031065) | 2.68170460 |
| 126 | regulation of water loss via skin (GO:0033561) | 2.58513730 |
| 127 | endodermal cell differentiation (GO:0035987) | 2.57157783 |
| 128 | semaphorin-plexin signaling pathway (GO:0071526) | 2.55685650 |
| 129 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.54360907 |
| 130 | cell adhesion mediated by integrin (GO:0033627) | 2.47009354 |
| 131 | barbed-end actin filament capping (GO:0051016) | 2.46903399 |
| 132 | hyaluronan catabolic process (GO:0030214) | 2.46264399 |
| 133 | cellular response to exogenous dsRNA (GO:0071360) | 2.45686861 |
| 134 | protein heterotrimerization (GO:0070208) | 2.44849144 |
| 135 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.43043327 |
| 136 | regulation of integrin activation (GO:0033623) | 2.42651017 |
| 137 | endocardial cushion development (GO:0003197) | 2.38872727 |
| 138 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.38330517 |
| 139 | protein retention in ER lumen (GO:0006621) | 2.37817573 |
| 140 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.37116485 |
| 141 | lung vasculature development (GO:0060426) | 2.36585742 |
| 142 | regulation of histone phosphorylation (GO:0033127) | 2.35409898 |
| 143 | negative regulation of viral entry into host cell (GO:0046597) | 2.29618900 |
| 144 | protein localization to endosome (GO:0036010) | 2.28680160 |
| 145 | negative regulation of protein autophosphorylation (GO:0031953) | 2.26768493 |
| 146 | cell-cell junction maintenance (GO:0045217) | 2.26614294 |
| 147 | negative regulation of viral release from host cell (GO:1902187) | 2.25230202 |
| 148 | endothelial cell morphogenesis (GO:0001886) | 2.24966217 |
| 149 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.23337353 |
| 150 | regulation of viral release from host cell (GO:1902186) | 2.23050697 |
| 151 | glomerular filtration (GO:0003094) | 2.21866860 |
| 152 | endosome organization (GO:0007032) | 2.21807670 |
| 153 | oligosaccharide catabolic process (GO:0009313) | 2.21178197 |
| 154 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.19147815 |
| 155 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.18676690 |
| 156 | establishment of skin barrier (GO:0061436) | 2.16030052 |
| 157 | keratinocyte proliferation (GO:0043616) | 2.14819427 |
| 158 | keratan sulfate catabolic process (GO:0042340) | 2.11594132 |
| 159 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.10726356 |
| 160 | GDP-mannose metabolic process (GO:0019673) | 2.10343094 |
| 161 | extracellular matrix disassembly (GO:0022617) | 2.09816107 |
| 162 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.08934690 |
| 163 | response to progesterone (GO:0032570) | 2.07794160 |
| 164 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.07780793 |
| 165 | activation of Rac GTPase activity (GO:0032863) | 2.07758593 |
| 166 | atrioventricular valve morphogenesis (GO:0003181) | 2.07102335 |
| 167 | glycosphingolipid catabolic process (GO:0046479) | 2.06988755 |
| 168 | cyclooxygenase pathway (GO:0019371) | 2.06850229 |
| 169 | positive regulation of osteoblast proliferation (GO:0033690) | 2.06456833 |
| 170 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.04188585 |
| 171 | apoptotic cell clearance (GO:0043277) | 2.03771242 |
| 172 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.03764953 |
| 173 | glutathione biosynthetic process (GO:0006750) | 2.03338775 |
| 174 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.01302525 |
| 175 | positive regulation of receptor recycling (GO:0001921) | 2.00639970 |
| 176 | regulation of interleukin-8 secretion (GO:2000482) | 2.00504201 |
| 177 | regulation of extracellular matrix disassembly (GO:0010715) | 1.99875641 |
| 178 | protein hydroxylation (GO:0018126) | 1.99259938 |
| 179 | regulation of early endosome to late endosome transport (GO:2000641) | 1.99018784 |
| 180 | multicellular organismal water homeostasis (GO:0050891) | 1.98818599 |
| 181 | diaphragm development (GO:0060539) | 1.98217464 |
| 182 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 1.97108969 |
| 183 | negative regulation of tumor necrosis factor production (GO:0032720) | 1.96848012 |
| 184 | negative regulation of interleukin-8 production (GO:0032717) | 1.96566275 |
| 185 | tooth mineralization (GO:0034505) | 1.96177945 |
| 186 | regulation of vitamin metabolic process (GO:0030656) | 1.95664086 |
| 187 | lysosome organization (GO:0007040) | 1.95069398 |
| 188 | lytic vacuole organization (GO:0080171) | 1.95069398 |
| 189 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 1.94818877 |
| 190 | glycolipid catabolic process (GO:0019377) | 1.94648424 |
| 191 | regulation of integrin-mediated signaling pathway (GO:2001044) | 1.94543962 |
| 192 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 1.94501153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.98104920 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.73528755 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.27593763 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.18501541 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.48707845 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.91917013 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.69057798 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.31576442 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.09505390 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.77973516 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.77558990 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.56857401 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.55882516 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.54154464 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.23759716 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.11612484 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.10132366 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.99815590 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.95392435 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.90244733 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89353326 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.74261100 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63768485 |
| 24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.62435738 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.61857235 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60828607 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59277705 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.58896204 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58665468 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58194445 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55530970 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.55254105 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50889677 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.48648370 |
| 35 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.46103553 |
| 36 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.45974197 |
| 37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.44924785 |
| 38 | P68_20966046_ChIP-Seq_HELA_Human | 1.44764173 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.44761981 |
| 40 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.43022823 |
| 41 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42314876 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41838086 |
| 43 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.39342433 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37894722 |
| 45 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35991172 |
| 46 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.35647176 |
| 47 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34666825 |
| 48 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33202909 |
| 49 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32720194 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.31159436 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28502955 |
| 52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28306190 |
| 53 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.28091249 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27536703 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25911693 |
| 56 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.25112867 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22331492 |
| 58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19603496 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18756210 |
| 60 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.18449954 |
| 61 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.18317128 |
| 62 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18098144 |
| 63 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17953405 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17880133 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17094287 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17065946 |
| 67 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.16963939 |
| 68 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.16496625 |
| 69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.16255554 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15871181 |
| 71 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.14383893 |
| 72 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.14383893 |
| 73 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.14383893 |
| 74 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13451238 |
| 75 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12989835 |
| 76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12883561 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12213973 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11654322 |
| 79 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.11217689 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10311949 |
| 81 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10204909 |
| 82 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.09883253 |
| 83 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09212301 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08923942 |
| 85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08483731 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07586958 |
| 87 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07523021 |
| 88 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07230799 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07175843 |
| 90 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06719092 |
| 91 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04863683 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03501242 |
| 93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03383068 |
| 94 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.02910971 |
| 95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02214474 |
| 96 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01094801 |
| 97 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00628248 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99847663 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99526455 |
| 100 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.98907254 |
| 101 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98410691 |
| 102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98368450 |
| 103 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98014826 |
| 104 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.98000095 |
| 105 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.97659458 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97486340 |
| 107 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.96883806 |
| 108 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96382600 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95656115 |
| 110 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95279505 |
| 111 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94816007 |
| 112 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.93800704 |
| 113 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93114423 |
| 114 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.92584769 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91557136 |
| 116 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91390763 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91136662 |
| 118 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90813749 |
| 119 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.90375279 |
| 120 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86680807 |
| 121 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86210520 |
| 122 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.85760015 |
| 123 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84200912 |
| 124 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83722539 |
| 125 | GATA1_22025678_ChIP-Seq_K562_Human | 0.81286022 |
| 126 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81261296 |
| 127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79901326 |
| 128 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79901326 |
| 129 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.78468802 |
| 130 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.78209911 |
| 131 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77550594 |
| 132 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77550594 |
| 133 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77543701 |
| 134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76538224 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76538224 |
| 136 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.75897531 |
| 137 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75359799 |
| 138 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.73179667 |
| 139 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73030956 |
| 140 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.71067089 |
| 141 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.70853744 |
| 142 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.69601191 |
| 143 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.69034721 |
| 144 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.68885900 |
| 145 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.68862889 |
| 146 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.68656584 |
| 147 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68599739 |
| 148 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67841908 |
| 149 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.67785982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.56854951 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.53805985 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.32044719 |
| 4 | MP0005365_abnormal_bile_salt | 4.19900495 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.65684000 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.49183588 |
| 7 | MP0003252_abnormal_bile_duct | 3.01630107 |
| 8 | MP0009840_abnormal_foam_cell | 2.92415332 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.69836884 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.68497817 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.67164929 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.65876552 |
| 13 | MP0004858_abnormal_nervous_system | 2.48503302 |
| 14 | MP0005083_abnormal_biliary_tract | 2.31684805 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.15757025 |
| 16 | MP0005332_abnormal_amino_acid | 2.04190681 |
| 17 | MP0010368_abnormal_lymphatic_system | 1.83102787 |
| 18 | MP0002254_reproductive_system_inflammat | 1.82270331 |
| 19 | MP0003011_delayed_dark_adaptation | 1.76852089 |
| 20 | MP0000609_abnormal_liver_physiology | 1.76507324 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 1.74998404 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.64923602 |
| 23 | MP0005275_abnormal_skin_tensile | 1.63623722 |
| 24 | MP0005076_abnormal_cell_differentiation | 1.60413915 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.56726211 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 1.53658323 |
| 27 | MP0003195_calcinosis | 1.52237259 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.52002066 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.39861134 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.38471979 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.37101585 |
| 32 | MP0005023_abnormal_wound_healing | 1.34238796 |
| 33 | MP0000467_abnormal_esophagus_morphology | 1.32215697 |
| 34 | MP0001542_abnormal_bone_strength | 1.31314044 |
| 35 | MP0004272_abnormal_basement_membrane | 1.31278179 |
| 36 | MP0000579_abnormal_nail_morphology | 1.30989219 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.25795276 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.25214315 |
| 39 | MP0001873_stomach_inflammation | 1.24511236 |
| 40 | MP0003279_aneurysm | 1.24128258 |
| 41 | MP0003186_abnormal_redox_activity | 1.23744691 |
| 42 | MP0002933_joint_inflammation | 1.23553754 |
| 43 | MP0001216_abnormal_epidermal_layer | 1.22044575 |
| 44 | MP0003091_abnormal_cell_migration | 1.21968133 |
| 45 | MP0004264_abnormal_extraembryonic_tissu | 1.21485599 |
| 46 | MP0005595_abnormal_vascular_smooth | 1.21312200 |
| 47 | MP0005257_abnormal_intraocular_pressure | 1.20681410 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.20129115 |
| 49 | MP0000678_abnormal_parathyroid_gland | 1.19393105 |
| 50 | MP0003950_abnormal_plasma_membrane | 1.16742799 |
| 51 | MP0001958_emphysema | 1.15132324 |
| 52 | MP0002896_abnormal_bone_mineralization | 1.12787139 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.11950481 |
| 54 | MP0002060_abnormal_skin_morphology | 1.11822991 |
| 55 | MP0003045_fibrosis | 1.10439875 |
| 56 | MP0004510_myositis | 1.10405813 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.10266454 |
| 58 | MP0000598_abnormal_liver_morphology | 1.10213661 |
| 59 | MP0003868_abnormal_feces_composition | 1.08648404 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08484570 |
| 61 | MP0003828_pulmonary_edema | 1.06397404 |
| 62 | MP0000538_abnormal_urinary_bladder | 1.06049528 |
| 63 | MP0005670_abnormal_white_adipose | 1.05535091 |
| 64 | MP0003879_abnormal_hair_cell | 1.02679728 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 1.02025562 |
| 66 | MP0002419_abnormal_innate_immunity | 1.00799511 |
| 67 | MP0003436_decreased_susceptibility_to | 1.00538084 |
| 68 | MP0002098_abnormal_vibrissa_morphology | 1.00400067 |
| 69 | MP0003183_abnormal_peptide_metabolism | 0.99038813 |
| 70 | MP0009764_decreased_sensitivity_to | 0.96866433 |
| 71 | MP0009384_cardiac_valve_regurgitation | 0.96488974 |
| 72 | MP0003724_increased_susceptibility_to | 0.95377530 |
| 73 | MP0000750_abnormal_muscle_regeneration | 0.93005829 |
| 74 | MP0005409_darkened_coat_color | 0.92698641 |
| 75 | MP0006054_spinal_hemorrhage | 0.92273986 |
| 76 | MP0009780_abnormal_chondrocyte_physiolo | 0.91084280 |
| 77 | MP0010771_integument_phenotype | 0.90523739 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.89351876 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.88517952 |
| 80 | MP0005501_abnormal_skin_physiology | 0.87911751 |
| 81 | MP0000383_abnormal_hair_follicle | 0.86594943 |
| 82 | MP0009053_abnormal_anal_canal | 0.84257105 |
| 83 | MP0001243_abnormal_dermal_layer | 0.84230434 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.83958674 |
| 85 | MP0002796_impaired_skin_barrier | 0.83823969 |
| 86 | MP0009763_increased_sensitivity_to | 0.83626676 |
| 87 | MP0006082_CNS_inflammation | 0.83425637 |
| 88 | MP0009931_abnormal_skin_appearance | 0.82764760 |
| 89 | MP0000762_abnormal_tongue_morphology | 0.82579192 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.81650052 |
| 91 | * MP0008469_abnormal_protein_level | 0.81507455 |
| 92 | MP0001348_abnormal_lacrimal_gland | 0.81383617 |
| 93 | * MP0005025_abnormal_response_to | 0.80970267 |
| 94 | MP0004043_abnormal_pH_regulation | 0.80035557 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.79837503 |
| 96 | MP0004233_abnormal_muscle_weight | 0.79778641 |
| 97 | MP0005503_abnormal_tendon_morphology | 0.79558972 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.78789580 |
| 99 | MP0001756_abnormal_urination | 0.77551114 |
| 100 | MP0000470_abnormal_stomach_morphology | 0.77175115 |
| 101 | MP0000343_altered_response_to | 0.76781417 |
| 102 | MP0005451_abnormal_body_composition | 0.75339502 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.75291387 |
| 104 | MP0002295_abnormal_pulmonary_circulatio | 0.74183531 |
| 105 | MP0000249_abnormal_blood_vessel | 0.71137387 |
| 106 | MP0001533_abnormal_skeleton_physiology | 0.70821793 |
| 107 | MP0001764_abnormal_homeostasis | 0.70587886 |
| 108 | MP0005164_abnormal_response_to | 0.70551582 |
| 109 | MP0004185_abnormal_adipocyte_glucose | 0.70164520 |
| 110 | MP0005084_abnormal_gallbladder_morpholo | 0.69322131 |
| 111 | MP0002971_abnormal_brown_adipose | 0.69312900 |
| 112 | MP0003303_peritoneal_inflammation | 0.68822926 |
| 113 | MP0004130_abnormal_muscle_cell | 0.68706990 |
| 114 | MP0005636_abnormal_mineral_homeostasis | 0.68591814 |
| 115 | MP0010030_abnormal_orbit_morphology | 0.67057324 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.66287963 |
| 117 | MP0009642_abnormal_blood_homeostasis | 0.65863529 |
| 118 | MP0002132_abnormal_respiratory_system | 0.65083750 |
| 119 | MP0005464_abnormal_platelet_physiology | 0.64390801 |
| 120 | MP0005220_abnormal_exocrine_pancreas | 0.63181142 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.63159616 |
| 122 | MP0009115_abnormal_fat_cell | 0.62810014 |
| 123 | MP0000767_abnormal_smooth_muscle | 0.62762521 |
| 124 | MP0004883_abnormal_blood_vessel | 0.62717822 |
| 125 | MP0004947_skin_inflammation | 0.62417863 |
| 126 | MP0003075_altered_response_to | 0.60522298 |
| 127 | MP0001849_ear_inflammation | 0.59160033 |
| 128 | MP0010155_abnormal_intestine_physiology | 0.58517801 |
| 129 | MP0000604_amyloidosis | 0.56009438 |
| 130 | MP0005508_abnormal_skeleton_morphology | 0.54925723 |
| 131 | MP0005248_abnormal_Harderian_gland | 0.54556339 |
| 132 | MP0003656_abnormal_erythrocyte_physiolo | 0.54410898 |
| 133 | MP0005334_abnormal_fat_pad | 0.53829112 |
| 134 | MP0000858_altered_metastatic_potential | 0.53568830 |
| 135 | MP0002135_abnormal_kidney_morphology | 0.52600768 |
| 136 | MP0005165_increased_susceptibility_to | 0.52221054 |
| 137 | MP0005408_hypopigmentation | 0.51966680 |
| 138 | MP0005390_skeleton_phenotype | 0.51602944 |
| 139 | MP0001879_abnormal_lymphatic_vessel | 0.50989980 |
| 140 | MP0002877_abnormal_melanocyte_morpholog | 0.50852542 |
| 141 | MP0002168_other_aberrant_phenotype | 0.49485129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.57956574 |
| 2 | Xanthomatosis (HP:0000991) | 4.97175437 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.80772674 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.80129995 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.68526689 |
| 6 | Complement deficiency (HP:0004431) | 4.09021209 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.00747880 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.84913518 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.84913518 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.84913518 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 3.84199406 |
| 12 | Protrusio acetabuli (HP:0003179) | 3.79841528 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.75277424 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.60148852 |
| 15 | Atrophic scars (HP:0001075) | 3.59731177 |
| 16 | Abnormality of the intrinsic pathway (HP:0010989) | 3.48980351 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.48860761 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 3.47213082 |
| 19 | Peritonitis (HP:0002586) | 3.46618830 |
| 20 | Hyperammonemia (HP:0001987) | 3.44883196 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.43349961 |
| 22 | Abnormality of complement system (HP:0005339) | 3.39803917 |
| 23 | Joint hemorrhage (HP:0005261) | 3.39409418 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 3.34494130 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.28118838 |
| 26 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.22286621 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.20317117 |
| 28 | Ketosis (HP:0001946) | 3.20250295 |
| 29 | Hyperglycinuria (HP:0003108) | 3.17150767 |
| 30 | Cervical subluxation (HP:0003308) | 3.13711177 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.01143049 |
| 32 | Dysostosis multiplex (HP:0000943) | 2.98389932 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.94596853 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 2.94596853 |
| 35 | Premature rupture of membranes (HP:0001788) | 2.93675599 |
| 36 | Fragile skin (HP:0001030) | 2.91530757 |
| 37 | Epidermoid cyst (HP:0200040) | 2.90486371 |
| 38 | Hypercholesterolemia (HP:0003124) | 2.89306939 |
| 39 | Myocardial infarction (HP:0001658) | 2.88947661 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.88261123 |
| 41 | Malnutrition (HP:0004395) | 2.86435562 |
| 42 | Alopecia of scalp (HP:0002293) | 2.83745513 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.83538065 |
| 44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.83538065 |
| 45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.83538065 |
| 46 | Abnormal cartilage morphology (HP:0002763) | 2.82098833 |
| 47 | Fat malabsorption (HP:0002630) | 2.79841764 |
| 48 | Milia (HP:0001056) | 2.78343174 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.78297887 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77379193 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.75127332 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.75127332 |
| 53 | Follicular hyperkeratosis (HP:0007502) | 2.69737186 |
| 54 | Skin nodule (HP:0200036) | 2.68938722 |
| 55 | Hyperacusis (HP:0010780) | 2.66700656 |
| 56 | Hyperglycinemia (HP:0002154) | 2.65693997 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.65326580 |
| 58 | Joint stiffness (HP:0001387) | 2.60790651 |
| 59 | Esophageal varix (HP:0002040) | 2.60093620 |
| 60 | Bladder diverticulum (HP:0000015) | 2.57979044 |
| 61 | Plantar hyperkeratosis (HP:0007556) | 2.55476427 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.54377434 |
| 63 | Cardiovascular calcification (HP:0011915) | 2.53786215 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.52947497 |
| 65 | Ketoacidosis (HP:0001993) | 2.52697190 |
| 66 | Amyloidosis (HP:0011034) | 2.51801722 |
| 67 | Vascular calcification (HP:0004934) | 2.48226831 |
| 68 | Broad face (HP:0000283) | 2.45519480 |
| 69 | Abnormality of the Achilles tendon (HP:0005109) | 2.44742755 |
| 70 | Gout (HP:0001997) | 2.44065127 |
| 71 | Abnormality of nucleobase metabolism (HP:0010932) | 2.42660427 |
| 72 | J-shaped sella turcica (HP:0002680) | 2.42659770 |
| 73 | Cheilitis (HP:0100825) | 2.40794645 |
| 74 | Hepatocellular carcinoma (HP:0001402) | 2.39461870 |
| 75 | Increased connective tissue (HP:0009025) | 2.38822180 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.38052560 |
| 77 | Focal segmental glomerulosclerosis (HP:0000097) | 2.34442687 |
| 78 | Right ventricular cardiomyopathy (HP:0011663) | 2.32172509 |
| 79 | Thin bony cortex (HP:0002753) | 2.31173430 |
| 80 | Coxa vara (HP:0002812) | 2.30676283 |
| 81 | Natal tooth (HP:0000695) | 2.29176304 |
| 82 | Abnormality of methionine metabolism (HP:0010901) | 2.26233315 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.24550822 |
| 84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.24550822 |
| 85 | Short nail (HP:0001799) | 2.23459066 |
| 86 | Hydroxyprolinuria (HP:0003080) | 2.22906944 |
| 87 | Abnormality of proline metabolism (HP:0010907) | 2.22906944 |
| 88 | Fragile nails (HP:0001808) | 2.22334412 |
| 89 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.19226411 |
| 90 | Broad metatarsal (HP:0001783) | 2.19119314 |
| 91 | Spastic diplegia (HP:0001264) | 2.19094143 |
| 92 | Hyperbilirubinemia (HP:0002904) | 2.18333256 |
| 93 | Hypochromic microcytic anemia (HP:0004840) | 2.17857421 |
| 94 | Glomerulonephritis (HP:0000099) | 2.13463166 |
| 95 | Thick nail (HP:0001805) | 2.13102707 |
| 96 | Elbow flexion contracture (HP:0002987) | 2.11235531 |
| 97 | Palmoplantar hyperkeratosis (HP:0000972) | 2.04704955 |
| 98 | Multiple enchondromatosis (HP:0005701) | 2.02966174 |
| 99 | Ovoid vertebral bodies (HP:0003300) | 2.02640802 |
| 100 | Nonimmune hydrops fetalis (HP:0001790) | 2.02509954 |
| 101 | Vascular tortuosity (HP:0004948) | 2.02163417 |
| 102 | Onycholysis (HP:0001806) | 2.01879900 |
| 103 | Metabolic acidosis (HP:0001942) | 2.01703105 |
| 104 | Steatorrhea (HP:0002570) | 2.01193574 |
| 105 | Aortic aneurysm (HP:0004942) | 2.01104039 |
| 106 | Aortic dissection (HP:0002647) | 1.99822164 |
| 107 | Achilles tendon contracture (HP:0001771) | 1.99716024 |
| 108 | Polycythemia (HP:0001901) | 1.99347303 |
| 109 | Mitral stenosis (HP:0001718) | 1.98694709 |
| 110 | Amelogenesis imperfecta (HP:0000705) | 1.98435600 |
| 111 | Nail dystrophy (HP:0008404) | 1.97772001 |
| 112 | Delayed CNS myelination (HP:0002188) | 1.97023084 |
| 113 | Lymphangioma (HP:0100764) | 1.96771887 |
| 114 | Abnormal hair laboratory examination (HP:0003328) | 1.95786746 |
| 115 | Hemorrhage of the eye (HP:0011885) | 1.95349932 |
| 116 | Nephritis (HP:0000123) | 1.94472243 |
| 117 | Breast hypoplasia (HP:0003187) | 1.94071655 |
| 118 | Glomerulosclerosis (HP:0000096) | 1.93581160 |
| 119 | Cardiomegaly (HP:0001640) | 1.92942797 |
| 120 | Ankle contracture (HP:0006466) | 1.92908645 |
| 121 | Gingival bleeding (HP:0000225) | 1.91886901 |
| 122 | Spontaneous abortion (HP:0005268) | 1.91615160 |
| 123 | Conjugated hyperbilirubinemia (HP:0002908) | 1.90633179 |
| 124 | Spondylolisthesis (HP:0003302) | 1.89760603 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.89615093 |
| 126 | Wormian bones (HP:0002645) | 1.89305772 |
| 127 | Cerebral aneurysm (HP:0004944) | 1.88070278 |
| 128 | Protuberant abdomen (HP:0001538) | 1.87791718 |
| 129 | Flat acetabular roof (HP:0003180) | 1.85770750 |
| 130 | Generalized aminoaciduria (HP:0002909) | 1.85369296 |
| 131 | Vertebral compression fractures (HP:0002953) | 1.85014217 |
| 132 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84564584 |
| 133 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.83364456 |
| 134 | Prolonged neonatal jaundice (HP:0006579) | 1.82918669 |
| 135 | Aneurysm (HP:0002617) | 1.82844467 |
| 136 | Hepatoblastoma (HP:0002884) | 1.82740292 |
| 137 | Menorrhagia (HP:0000132) | 1.82593367 |
| 138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82469929 |
| 139 | Late onset (HP:0003584) | 1.80897855 |
| 140 | Mitral valve prolapse (HP:0001634) | 1.80783396 |
| 141 | Abnormal tarsal ossification (HP:0008369) | 1.80167555 |
| 142 | Interstitial pulmonary disease (HP:0006530) | 1.78980174 |
| 143 | Distal lower limb muscle weakness (HP:0009053) | 1.78275890 |
| 144 | Ectopia lentis (HP:0001083) | 1.77915727 |
| 145 | Upper limb amyotrophy (HP:0009129) | 1.77444241 |
| 146 | Distal upper limb amyotrophy (HP:0007149) | 1.77444241 |
| 147 | Pancreatitis (HP:0001733) | 1.76619897 |
| 148 | Abdominal distention (HP:0003270) | 1.76413251 |
| 149 | Increased serum ferritin (HP:0003281) | 1.76254385 |
| 150 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76177331 |
| 151 | Arterial tortuosity (HP:0005116) | 1.74841819 |
| 152 | Long toe (HP:0010511) | 1.74669744 |
| 153 | Abnormal delivery (HP:0001787) | 1.74135630 |
| 154 | Spinal rigidity (HP:0003306) | 1.73659973 |
| 155 | Polygenic inheritance (HP:0010982) | 1.73451820 |
| 156 | Axonal loss (HP:0003447) | 1.73432913 |
| 157 | Blue sclerae (HP:0000592) | 1.72962057 |
| 158 | Abnormal blistering of the skin (HP:0008066) | 1.72807772 |
| 159 | Asymmetric septal hypertrophy (HP:0001670) | 1.72371892 |
| 160 | Shallow orbits (HP:0000586) | 1.70831868 |
| 161 | Palmar hyperkeratosis (HP:0010765) | 1.70718247 |
| 162 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.70598260 |
| 163 | Soft skin (HP:0000977) | 1.70551155 |
| 164 | Bradycardia (HP:0001662) | 1.69848012 |
| 165 | Femoral bowing (HP:0002980) | 1.69531721 |
| 166 | Loss of speech (HP:0002371) | 1.68986771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.03249833 |
| 2 | TRIB3 | 3.85487224 |
| 3 | BCKDK | 3.25725182 |
| 4 | PKN2 | 2.93639448 |
| 5 | SIK1 | 2.83307349 |
| 6 | TGFBR2 | 2.62521159 |
| 7 | MST1R | 2.35922214 |
| 8 | FGFR4 | 2.22797864 |
| 9 | RIPK1 | 2.11374435 |
| 10 | TTN | 1.84279503 |
| 11 | PTK6 | 1.74592436 |
| 12 | KDR | 1.65303040 |
| 13 | PRKD2 | 1.63663730 |
| 14 | ICK | 1.62396134 |
| 15 | GRK6 | 1.61613424 |
| 16 | PRKG2 | 1.52594459 |
| 17 | PAK4 | 1.51872867 |
| 18 | CDK12 | 1.47733399 |
| 19 | MAP2K3 | 1.42322521 |
| 20 | TBK1 | 1.42267035 |
| 21 | MAP3K3 | 1.41356709 |
| 22 | CDC42BPA | 1.40248511 |
| 23 | EPHB1 | 1.39973590 |
| 24 | EPHB2 | 1.38727205 |
| 25 | FLT3 | 1.37118113 |
| 26 | PDGFRA | 1.35489863 |
| 27 | TIE1 | 1.35326432 |
| 28 | MYLK | 1.34651187 |
| 29 | MAP3K10 | 1.31721124 |
| 30 | LRRK2 | 1.30679477 |
| 31 | CSF1R | 1.29660668 |
| 32 | EPHA2 | 1.26100004 |
| 33 | LATS1 | 1.25443571 |
| 34 | SMG1 | 1.22289099 |
| 35 | NEK9 | 1.20948806 |
| 36 | ADRBK2 | 1.20274433 |
| 37 | PTK2 | 1.18631133 |
| 38 | ACVR1B | 1.17623934 |
| 39 | MET | 1.11987427 |
| 40 | WNK4 | 1.10294807 |
| 41 | DDR2 | 1.10200256 |
| 42 | LIMK1 | 1.09491177 |
| 43 | BMX | 1.09165591 |
| 44 | PIK3CG | 1.08323396 |
| 45 | TAOK3 | 1.07604747 |
| 46 | STK38 | 1.07536467 |
| 47 | STK10 | 1.05964256 |
| 48 | TYK2 | 1.05426501 |
| 49 | MAP2K2 | 1.04644263 |
| 50 | PDPK1 | 1.02120795 |
| 51 | MATK | 1.01424996 |
| 52 | IRAK4 | 1.01411255 |
| 53 | ABL2 | 1.00069017 |
| 54 | ADRBK1 | 0.98312402 |
| 55 | NTRK1 | 0.98231267 |
| 56 | MAPK15 | 0.96346736 |
| 57 | MAP3K7 | 0.95465519 |
| 58 | MOS | 0.93431068 |
| 59 | RPS6KA2 | 0.92009127 |
| 60 | CSK | 0.88835767 |
| 61 | RPS6KA6 | 0.88435445 |
| 62 | KIT | 0.88190838 |
| 63 | FRK | 0.87019432 |
| 64 | TLK1 | 0.86804450 |
| 65 | ERBB4 | 0.86606749 |
| 66 | EPHA3 | 0.86547139 |
| 67 | PAK2 | 0.85707659 |
| 68 | PIK3CA | 0.84963449 |
| 69 | LMTK2 | 0.84106762 |
| 70 | MAP3K6 | 0.83651667 |
| 71 | FGFR3 | 0.82243515 |
| 72 | PIM2 | 0.80704709 |
| 73 | CAMK1D | 0.79234602 |
| 74 | GRK1 | 0.78604403 |
| 75 | MAPK7 | 0.77307941 |
| 76 | LATS2 | 0.74897915 |
| 77 | MAPK11 | 0.74549467 |
| 78 | PTK2B | 0.74144569 |
| 79 | PRKCI | 0.70496510 |
| 80 | PDGFRB | 0.68470816 |
| 81 | AKT3 | 0.68465266 |
| 82 | TAOK2 | 0.68172168 |
| 83 | JAK1 | 0.67473194 |
| 84 | CDK6 | 0.67325139 |
| 85 | MARK2 | 0.67111716 |
| 86 | EEF2K | 0.66169244 |
| 87 | TGFBR1 | 0.66096908 |
| 88 | RPS6KC1 | 0.65681575 |
| 89 | RPS6KL1 | 0.65681575 |
| 90 | JAK2 | 0.65237835 |
| 91 | HIPK2 | 0.64649686 |
| 92 | MAP3K1 | 0.63644076 |
| 93 | MAP3K11 | 0.63456635 |
| 94 | FER | 0.61211312 |
| 95 | MAP2K1 | 0.60814174 |
| 96 | IRAK3 | 0.60499881 |
| 97 | NME2 | 0.60498490 |
| 98 | MAPKAPK2 | 0.60425500 |
| 99 | MTOR | 0.59447266 |
| 100 | DYRK1B | 0.58835016 |
| 101 | GSK3A | 0.55567828 |
| 102 | IRAK1 | 0.54764567 |
| 103 | GRK5 | 0.53987466 |
| 104 | ERBB2 | 0.53912220 |
| 105 | BLK | 0.53408607 |
| 106 | MAPKAPK3 | 0.52581973 |
| 107 | TESK1 | 0.51679443 |
| 108 | INSRR | 0.51219396 |
| 109 | RPS6KA4 | 0.50674622 |
| 110 | PRKAA2 | 0.50483273 |
| 111 | MAPK4 | 0.48344678 |
| 112 | DAPK3 | 0.46266604 |
| 113 | ILK | 0.46068643 |
| 114 | GRK7 | 0.44373336 |
| 115 | ZAP70 | 0.44209826 |
| 116 | MAP2K6 | 0.43537803 |
| 117 | IGF1R | 0.42070014 |
| 118 | MAPK12 | 0.41726328 |
| 119 | MUSK | 0.41576976 |
| 120 | SCYL2 | 0.41499353 |
| 121 | STK3 | 0.40643532 |
| 122 | CAMK4 | 0.39800136 |
| 123 | PRKD3 | 0.37952817 |
| 124 | TAOK1 | 0.37248096 |
| 125 | MAP3K2 | 0.36281205 |
| 126 | MAP3K14 | 0.35475571 |
| 127 | IKBKB | 0.35299464 |
| 128 | STK38L | 0.35147705 |
| 129 | TTK | 0.34604069 |
| 130 | JAK3 | 0.34314532 |
| 131 | CHUK | 0.34198250 |
| 132 | RPS6KB2 | 0.33939316 |
| 133 | TRPM7 | 0.32646216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.58373007 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34069655 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.76524091 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.67211189 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61950553 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.58184456 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.56388784 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.49545349 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.49410824 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37804765 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.29526800 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.26920884 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.19106614 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.11064310 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.08333579 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.07207220 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06601902 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.00743245 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.95670544 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80484981 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.80350652 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76457011 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76209513 |
| 24 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.73623997 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73216311 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68070484 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.65042787 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62089224 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61690505 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55965427 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.55566296 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.54904394 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51810550 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.51497573 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47342576 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42833467 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36176488 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.33539182 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33246645 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25882901 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25036563 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21008835 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18409922 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12225025 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09158274 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09030883 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06886498 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06203181 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05323358 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02699647 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00973605 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00944828 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.00394062 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97699047 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97571424 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96704764 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95209227 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92462151 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91934203 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90491770 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89717816 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.87434180 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83983951 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82071935 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80879881 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79305697 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79114611 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78794716 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.78285868 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77939928 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76155942 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75795278 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75065037 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74846149 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74630152 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70641032 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70362931 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69748538 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68411335 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66371781 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65066167 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64975068 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.64184403 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63415592 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63061626 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56506307 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55594037 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55358533 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55339194 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54750407 |
| 91 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54116379 |
| 92 | Influenza A_Homo sapiens_hsa05164 | 0.53510750 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53323362 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52199660 |
| 95 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51908943 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50544584 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49846038 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.49329994 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.49314518 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.48974588 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.48656641 |
| 102 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48365813 |
| 103 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.47428737 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47190816 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.46686863 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46073693 |
| 107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41556045 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41425624 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40546689 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.38844344 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38685967 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37066640 |
| 113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36506857 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35928803 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35583383 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.35560883 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.33733255 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33209960 |
| 119 | Malaria_Homo sapiens_hsa05144 | 0.32993055 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.31932857 |
| 121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29104484 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.28646424 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25230608 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.24709157 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20742403 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20005354 |
| 127 | Pertussis_Homo sapiens_hsa05133 | 0.19885655 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | 0.18314043 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16990830 |
| 130 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16716158 |
| 131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.16398719 |
| 132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14859060 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14553605 |
| 134 | Hepatitis C_Homo sapiens_hsa05160 | 0.13434521 |
| 135 | Legionellosis_Homo sapiens_hsa05134 | 0.11695415 |
| 136 | Leishmaniasis_Homo sapiens_hsa05140 | 0.10818215 |

